Skip to the main content.

1 min read

2022 MMIT Patient Choice Awards Finalist

2022 MMIT Patient Choice Awards Finalist | Senderra

Senderra is a 2022 MMIT Patient Choice Awards Finalist!

7th Annual MMIT Patient Choice Awards

Patient Choice Award 3-1

Senderra is a finalist in the Managed Markets Insight & Technology (MMIT) seventh-annual Specialty Pharmacy Patient Choice Awards as ranked by patient satisfaction survey results from the previous year.

Each year, MMIT recognizes specialty pharmacies that provide best-in-class customer satisfaction and overall patient care.

2022 Award Finalist

Senderra is honored to be a finalist this year in the Independent Specialty Pharmacy category. This honor confirms Senderra’s ongoing commitment to keeping people first and providing exceptional patient care.

New call-to-action


About senderra

Senderra-Logo_Mark-Only_COLOR-1Senderra is a national specialty pharmacy, serving patients with challenging and ongoing medical conditions through provision of specialty medicationsclinical expertise and support services

We dedicate ourselves to designing and executing a model to serve the needs of our patients and partners (PrescribersPharma and Payers) in order to make a difference and effect positive outcomes. 

2022 MMIT Patient Choice Awards Finalist

Senderra is a 2022 MMIT Patient Choice Awards Finalist!

Read More

D2 Solutions and Senderra Specialty Pharmacy launch UltraTouch™

D2 Solutions and Senderra Specialty Pharmacy launch UltraTouch™, a network collaboration to improve market access for patient services for specialty...

Read More

Senderra Attends Forum At The US House Of Representatives

Senderra's Vice President Of Regulatory And Compliance, Tiffany Jones, attended a forum on the impact of pharmacy benefit managers (PBMs) in...

Read More